Health and Healthcare

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

577 Articles

Chris Lange | Apr 26, 2019 at 8:45 AM EDT

Big Pharma Scares Off Short Sellers

The April 15 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Apr 24, 2019 at 12:55 PM EDT

Top Biotech Stocks and ETFs: A Sector in Trouble or a Huge Bargain

24/7 Wall St. has looked over some of the biotech sector's laggards, and we have also looked over the top…

Chris Lange | Apr 10, 2019 at 9:40 AM EDT

Unbelievable Swings in Big Pharma Short Interest

The March 29 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Mar 27, 2019 at 8:50 AM EDT

Major Pharma Sees a Few Wild Swings in Short Interest

The March 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Mar 12, 2019 at 8:35 AM EDT

Big Pharma Short Interest Backs Off, With One Huge Exception

The February 28 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Feb 28, 2019 at 8:30 AM EST

Major Pharma Sees Tremendous Rise in Short Interest

The February 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Feb 12, 2019 at 9:35 AM EST

Major Pharma Scares Off Short Sellers

The January 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Jan 29, 2019 at 3:01 PM EST

Reality Check: Big Biotech and Big Pharma Are Becoming Identical

There is great opportunity in healthcare. There is also quite a lot of risk. Politicians and consumers alike want lower…

Chris Lange | Jan 28, 2019 at 10:10 AM EST

Short Interest Spikes in a Couple Major Pharma Stocks

The January 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Trey Thoelcke | Jan 26, 2019 at 9:00 AM EST

The 6 Most Shorted NYSE Stocks

Judging by the most shorted stocks traded on the New York Stock Exchange between the December 31 and January 15…

Chris Lange | Jan 24, 2019 at 10:25 AM EST

Why the Bristol-Myers Incredible Earnings Beat Is Getting Grounded

Bristol-Myers Squibb reported better-than-expected quarterly results before the markets opened on Thursday.

Chris Lange | Jan 11, 2019 at 9:50 AM EST

Major Pharma Sees Fading Short Interest

The December 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jan 3, 2019 at 4:08 PM EST

Thursday’s Biggest Winners and Losers in the S&P 500

Thursday was a down day for the broad U.S. markets. After a fairly decent Wednesday, markets as a whole took…

Paul Ausick | Jan 3, 2019 at 4:02 PM EST

Apple, Bristol-Myers Plummet into Thursday’s 52-Week Low Club

Apple, Bristol-Myers, Delta Air Lines, and United Continental all posted new 52-week lows on Thursday.

Paul Ausick | Jan 3, 2019 at 8:50 AM EST

Bristol-Myers, Celgene to Tie a $74 Billion Knot

Bristol-Myers has announced a definitive agreement to acquire rival Celgene in a cash and stock deal worth $74 billion. Celgene…

1 … 12 13 14 15 16 … 39

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Big Pharma Scares Off Short Sellers

Top Biotech Stocks and ETFs: A Sector in Trouble or a Huge Bargain

Unbelievable Swings in Big Pharma Short Interest

Major Pharma Sees a Few Wild Swings in Short Interest

Big Pharma Short Interest Backs Off, With One Huge Exception

Major Pharma Sees Tremendous Rise in Short Interest

Major Pharma Scares Off Short Sellers

Reality Check: Big Biotech and Big Pharma Are Becoming Identical

Short Interest Spikes in a Couple Major Pharma Stocks

The 6 Most Shorted NYSE Stocks

Why the Bristol-Myers Incredible Earnings Beat Is Getting Grounded

Major Pharma Sees Fading Short Interest

Thursday’s Biggest Winners and Losers in the S&P 500

Apple, Bristol-Myers Plummet into Thursday’s 52-Week Low Club

Bristol-Myers, Celgene to Tie a $74 Billion Knot

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Big Pharma Scares Off Short Sellers

Top Biotech Stocks and ETFs: A Sector in Trouble or a Huge Bargain

Unbelievable Swings in Big Pharma Short Interest

Major Pharma Sees a Few Wild Swings in Short Interest

Big Pharma Short Interest Backs Off, With One Huge Exception

Major Pharma Sees Tremendous Rise in Short Interest

Major Pharma Scares Off Short Sellers

Reality Check: Big Biotech and Big Pharma Are Becoming Identical

Short Interest Spikes in a Couple Major Pharma Stocks

The 6 Most Shorted NYSE Stocks

Why the Bristol-Myers Incredible Earnings Beat Is Getting Grounded

Major Pharma Sees Fading Short Interest

Thursday’s Biggest Winners and Losers in the S&P 500

Apple, Bristol-Myers Plummet into Thursday’s 52-Week Low Club

Bristol-Myers, Celgene to Tie a $74 Billion Knot

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%